SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals

被引：0
作者：
Kelin She
Shenghua Fang
Wei Du
Xingxing Fan
Jiaxi He
Hui Pan
Liyan Huang
Ping He
Jun Huang
机构：
[1] The First Affiliated Hospital of Guangzhou Medical University,Department of Thoracic Surgery
[2] Guangzhou Research Institute of Respiratory Disease,Department of Thoracic Surgery
[3] China Key Laboratory of Respiratory Disease,Department of Pathology
[4] National Center for Clinical Trials on Respiratory Diseases,undefined
[5] The Central Hospital of Shaoyang City,undefined
[6] Affiliated Cancer Hospital & Institute of Guangzhou Medical University,undefined
[7] Dongguan People’s Hospital,undefined
[8] State Key Laboratory of Quality Research in Chinese Medicine,undefined
[9] Macau Institute for Applied Research in Medicine and Health,undefined
[10] Macau University of Science and Technology,undefined
[11] The First Affiliated Hospital of Guangzhou Medical University,undefined
来源：
Cancer Cell International | / 19卷
关键词：
SCD1; EGFR; AKT; EMT; Lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] [6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling
    Jiang, Xueyi
    Wang, Jie
    Chen, Peng
    He, Zhiwei
    Xu, Jian
    Chen, Yankun
    Liu, Xinyuan
    Jiang, Jianxin
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [32] [6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling
    Xueyi Jiang
    Jie Wang
    Peng Chen
    Zhiwei He
    Jian Xu
    Yankun Chen
    Xinyuan Liu
    Jianxin Jiang
    Cancer Cell International, 21
  • [33] Regulatory effects of miRNAs targeting PI3K/AKT signaling pathway in the pathogenesis of lung cancer
    Sharanya, K.
    Mandal, A. K. A.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2024, 19 (03): : 135 - 141
  • [34] Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway
    Shao, Jingwei
    Zheng, Guirong
    Chen, Hongning
    Liu, Jian
    Xu, Aixiao
    Chen, Fan
    Li, Tao
    Lu, Yusheng
    Xu, Jianguo
    Zheng, Ning
    Jia, Lee
    ONCOTARGET, 2017, 8 (45) : 78351 - 78364
  • [35] Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
    Tong, Xin
    Pelling, Jill C.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 971 - 978
  • [36] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
    Li, Huayi
    Prever, Lorenzo
    Hirsch, Emilio
    Gulluni, Federico
    CANCERS, 2021, 13 (14)
  • [37] Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells
    Yi, Yong Weon
    Hong, Wooyoung
    Kang, Hyo Jin
    Kim, Hee Jeong
    Zhao, Wenjing
    Wang, Antai
    Seong, Yeon-Sun
    Bae, Insoo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (05) : 648 - 656
  • [38] Drug discovery approaches targeting the PI3K/Akt pathway in cancer
    C Garcia-Echeverria
    W R Sellers
    Oncogene, 2008, 27 : 5511 - 5526
  • [39] Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
    Kwang-Yu Chang
    Shan-Yin Tsai
    Shang-Hung Chen
    Hsiao-Hui Tsou
    Chia-Jui Yen
    Ko-Jiunn Liu
    Hsun-Lang Fang
    Hung-Chang Wu
    Bin-Fay Chuang
    Shao-Wen Chou
    Careen K Tang
    Shyun-Yeu Liu
    Pei-Jung Lu
    Ching-Yu Yen
    Jang-Yang Chang
    Journal of Biomedical Science, 20
  • [40] Naphthoquinone Derivatives from the Endophytic Fungus Fusarium solani Induce Pancreatic Cancer Cells Apoptosis via Targeting EGFR-Mediated PI3K/Akt Pathway
    Gao, Lin-Lin
    Fang, Xu-Tong
    Zhao, Shu-Hui
    Hui, Chen-Xiao
    Huang, Wei-Wei
    Gao, Yu-Qi
    Gao, Jin-Ming
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2024, 72 (47) : 26209 - 26223
12345